As another example, lncAMPC activates LIF/LIFR/Jak1/STAT3 pathway to stable PD-L1 and metastasis-associated genes, thereby contributing to metastasis and immunosuppression in prostate cancer (Zhang et al., 2020). This evidence concerns the gene LIFR and prostate carcinoma.